CrossRef Nutrition in MASLD: a patient focused, evidence-based clinicians guide Katrina Pekarska, Paul N Brennan, Dana Ivancovsky Wajcman, Jennifer Towey, Leah Cox, Katie Weatherby, Stuart McPherson, Jonathan Stine, Jose Willemse, Wenhao Li, William Alazawi, Jeffrey V Lazarus, Richard Parker Frontline Gastroenterology .2026
For weight loss, the starting dose is usually 0.25 mg once a week for the first four weeks
Ozempic's once-weekly injection schedule, its demonstrated 1.5-1.8% HbA1c reduction, and the SUSTAIN cardiovascular outcomes trial data showing 26% reduction in major cardiovascular events in T2DM patients with established cardiovascular disease collectively built a clinical case that endocrinologists and cardiologists find compelling for guideline-aligned prescribing
Absolutely love Vitastir
At The Institute for Weight Management, we view this first week as a retraining period
FODMAPs are a catch-22: For most of us, they are beneficial additions to our gut